Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.79+0.09 (+0.61%)
Close on Nov 17, 2026Market cap $12.34BP/E 27.1Yield 0.57%
Dr Reddys Laboratories operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2026 it was ₹56.76B, up 22.2% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is ₹58.88B in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | ₹56.76B | +22.2% |
| FY2025 | Mar 31, 2025 | ₹46.43B | +2.2% |
| FY2024 | Mar 31, 2024 | ₹45.43B | -22.8% |
| FY2023 | Mar 31, 2023 | ₹58.88B | +109.5% |
| FY2022 | Mar 31, 2022 | ₹28.11B | -21.3% |
| FY2021 | Mar 31, 2021 | ₹35.70B | +19.6% |
| FY2020 | Mar 31, 2020 | ₹29.84B | +4.0% |
| FY2019 | Mar 31, 2019 | ₹28.70B | +59.2% |
| FY2018 | Mar 31, 2018 | ₹18.03B | -16.2% |
| FY2017 | Mar 31, 2017 | ₹21.51B | -47.8% |
| FY2016 | Mar 31, 2016 | ₹41.25B | – |
See a number that looks wrong?